Federal legislation and the advancement of neonatal drug studies.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

9 citing papers in PubMed.

1. Pharmacokinetics of Oral Methadone in the Treatment of Neonatal Abstinence Syndrome: A Pilot Study.The Journal of pediatrics · 2015
   Trial
2. New Information on Old Medicinal Products: A Cross-Sectional Analysis of Guidance for Paediatric Use for Substances on the European Priority List of Off-Patent Medicinal Products.Paediatric drugs · 2022
   Article
3. Suggestions for Model-Informed Precision Dosing to Optimize Neonatal Drug Therapy.Journal of clinical pharmacology · 2019
   Review
4. Outcomes Research in Vulnerable Pediatric Populations.Journal of neurosurgical anesthesiology · 2019
   Review
5. Monitoring neonates for ototoxicity.International journal of audiology · 2018
   Review
6. Use of off-label and unlicensed medicines in neonatal intensive care.PloS one · 2018
   Article
7. The role and limitations of Cochrane reviews at the bedside: a systematic synopsis of five pediatric subspecialties.Wiener medizinische Wochenschrift (1946) · 2017
   Article
8. Current management of neonatal abstinence syndrome secondary to intrauterine opioid exposure.The Journal of pediatrics · 2014
   Article
9. Pharmacological options for BPD prevention: steps for better clinical trial design.Journal of perinatology : official journal of the California Perinatal Association · 2014
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

3 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as